DSpace Repository

Serum levels of allopregnanolone in migraine patients: A case–control study

Show simple item record

dc.creator Delikanlı, Makpere
dc.creator Beceren, Nesrin Gökben
dc.creator Armağan, Hamit Hakan
dc.creator Korkut, Mustafa
dc.creator Bedel, Cihan
dc.date 2021-02-01T00:00:00Z
dc.date.accessioned 2021-12-03T12:02:42Z
dc.date.available 2021-12-03T12:02:42Z
dc.identifier cbc24275-a38d-4ead-9cd6-276cbf817e6a
dc.identifier https://avesis.sdu.edu.tr/publication/details/cbc24275-a38d-4ead-9cd6-276cbf817e6a/oai
dc.identifier.uri http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/94905
dc.description <p>Abstract:</p><p>INTRODUCTION: Migraine is a very common disorder and the mechanisms contributing to headache</p><p>still remain controversial. Allopregnanolone (AP) is a neurosteroid metabolite of progesterone.</p><p>Previously, there were some studies of AP on the positive effects of many diseases.</p><p>OBJECTIVES: The aim of this study was to evaluate AP levels in patients with migraine and compare</p><p>with levels measured in healthy individuals.</p><p>MATERIALS AND METHODS: This case–control study included fifty patients with acute migraine</p><p>headache who were previously diagnosed with migraine and fifty sex‑ and age‑matched healthy</p><p>volunteers with no headache complaints. Migraine patients who fulfilled the International Headache</p><p>Classification criteria of migraine and healthy controls were included in this study. Plasma AP levels</p><p>were compared in both groups.</p><p>RESULTS: Fifty patients (35 females and 15 males) and fifty healthy volunteers (38 females and</p><p>12 males) fulfilled the inclusion criteria and were enrolled in the study. AP levels of migraine patients</p><p>and control group were compared; there was a statistically significant difference between the two groups</p><p>(1.22 ± 1.92, 6.07 ± 4.89, respectively; P &lt; 0.001). AP levels were significantly higher in healthy people.</p><p>CONCLUSION: This study showed that low AP levels were detected in migraine patients. These</p><p>markers may contribute to our understanding of the pathophysiology of migraine.</p><p>Keywords:</p><p>Allopregnanolone, headache, migraine</p><p>Introduction</p><p>Migraine is a widespread disease in</p><p>emergency departments (ED), which</p><p>is characterized by unilateral, throbbing</p><p>headaches with moderate or severe intensity,</p><p>and can affect the quality of life. Nausea,</p><p>vomiting, anorexia, and lightheadedness</p><p>are some of the most common associated</p><p>signs and symptoms.[1,2] It is the third to</p><p>most common disorder with a worldwide</p><p>prevalence of 14.7%.[3‑5] Because of its</p><p>high prevalence and destructive nature,</p><p>the mechanisms contributing to migraine</p><p>headaches have been extensively studied</p><p>for</p>
dc.language eng
dc.rights info:eu-repo/semantics/openAccess
dc.title Serum levels of allopregnanolone in migraine patients: A case–control study
dc.type info:eu-repo/semantics/article


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account